Proposed Data Collections Submitted for Public Comment and Recommendations, 26969-26970 [E6-7019]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices
Tuberculous Mycobacterium (NTM)
Drug Susceptibility Testing (0920–
0600)—Extension—National Center for
Health Marketing (NCHM), Coordinating
Center for Health Information and
Service (CoCHIS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to
support both domestic and global public
health objectives for treatment of
tuberculosis (TB), prevention of multidrug resistance and surveillance
programs, the Division of Laboratory
Systems seeks to continue to collect
information from domestic private
clinical and public health laboratories
twice per year. Participation and
information collections from
international laboratories are limited to
those which have public health
responsibilities for tuberculosis drug
susceptibility testing and approval by
26969
Information collected in this program
includes the susceptibility test results of
primary and secondary drugs,
concentrations, and test methods
performed by laboratories on a set of
challenge isolates sent twice yearly. A
portion of the response instrument
collects demographic data such as
laboratory type and the number of tests
performed annually. By providing an
evaluation program to assess the ability
of the laboratories to test for drug
resistant M. tuberculosis and selected
strains of NTM, laboratories have a selfassessment tool to aid in maximizing
their skills in susceptibility testing.
Information obtained from laboratories
on susceptibility testing practices and
procedures assists with determining
variables related to good performance,
with assessing areas for training and
with developing practice standards.
There are no cost to the respondents
other than their time.
their national tuberculosis program.
While the overall number of cases of TB
in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
The rate of TB cases detected in foreignborn persons has been reported to be
almost nine times higher than the rate
among the U.S. born population.
CDC’s goal to eliminate TB will be
virtually impossible without
considerable effort in assisting countries
with heavy disease burden in the
reduction of tuberculosis. The
M.tuberculosis/NTM program supports
this role by monitoring the level of
performance and practices among
laboratories performing M. tuberculosis
susceptibility within the U.S, as well as
internationally, to ensure high-quality
laboratory testing, resulting in accurate
and reliable results.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
No. of respondents
Average number of responses per
respondent
Average burden per response
(in hours)
Domestic Private/Public Laboratories ..............................................................
International Laboratories (with public health responsibilities) ........................
Total ..........................................................................................................
165
165
........................
1
1
........................
30/60
30/60
........................
Dated: May 1, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7002 Filed 5–8–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–0469]
mstockstill on PROD1PC68 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
VerDate Aug<31>2005
15:42 May 08, 2006
Jkt 208001
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Program of Cancer
Registries—Cancer Surveillance
System—Extension (OMB number
0920–0469)—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Total burden
hours
83
83
166
Background and Brief Description
The American Cancer Society
estimated that about 1.37 million
Americans were newly diagnosed with
cancer in 2005 and that about 570,000
died from cancer in that same year. The
National Institutes of Health estimates
that in 2005, the cost of cancer was
about $209 billion, including $74 billion
direct costs to treat cancer, and $136
billion indirect costs in lost productivity
due to illness and premature death.
In 2002, CDC implemented the
National Program of Cancer Registries
(NPCR)—Cancer Surveillance System
(CSS) to collect, evaluate and
disseminate cancer incidence data
collected by population-based cancer
registries. In 2002, CDC began annually
publishing United States Cancer
Statistics (USCS). The latest USCS
report published in 2005 provided
cancer statistics for 93% of the United
States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, at the national level, cancer
incidence data were available for only
14% of the population of the United
States.
With this expanded coverage of the
U.S. population, it will now be possible
E:\FR\FM\09MYN1.SGM
09MYN1
26970
Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices
to better describe geographic variation
in cancer incidence throughout the
country and provide incidence data on
minority populations and rare cancers
to further plan and evaluate state and
national cancer control and prevention
efforts.
Therefore, CDCs, NCCDPHP, Division
of Cancer Prevention and Control
proposes to continue to aggregate
existing cancer incidence data from
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through to 12
months past the close of the most recent
diagnosis year (e.g., 2004).
NCCPHP is requesting a 3-year
clearance for this project. There are no
costs to respondents except their time to
participate in the survey.
states funded by the National Program
of Cancer Registries into a national
surveillance system.
These data are already collected and
aggregated at the state level. Thus the
additional burden for the states is small.
Funded states are asked to continue to
report cancer incidence data to CDC on
an annual basis. Each state is requested
to report a cumulative file containing
incidence data from the first diagnosis
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
resondent
Number of
respondents
Respondents
Average
burden per response
(in hours)
Total burden
hours
States, Territories, and the District of Columbia (Cancer Registries) .............
63
1
2
126
Total ..........................................................................................................
........................
........................
........................
126
Dated: May 3, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7019 Filed 5–8–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Heritable
Disorders and Genetic Diseases in
Newborns and Children; Notice of
Meeting
mstockstill on PROD1PC68 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Heritable
Disorders and Genetic Diseases in Newborns
and Children (ACHDGDNC).
Dates and Times: June 5, 2006, 9 a.m. to
5 p.m. June 6, 2006, 8:30 a.m. to 3 p.m.
Place: Four Points Sheraton Downtown,
Franklin AB Room, 1201 K Street, NW.,
Washington, DC 20005.
Status: The meeting will be open to the
public with attendance limited to space
availability.
Purpose: The Advisory Committee
provides advice and recommendations
concerning the grants and projects authorized
under the Heritable Disorders Program and
technical information to develop policies and
priorities for this program. The Heritable
Disorders Program was established to
enhance the ability of State and local health
agencies to provide for newborn and child
screening, counseling and health care
services for newborns and children having or
at risk for heritable disorders. The Committee
was established specifically to advise and
guide the Secretary regarding the most
appropriate application of universal newborn
VerDate Aug<31>2005
15:42 May 08, 2006
Jkt 208001
screening tests, technologies, policies,
guidelines and programs for effectively
reducing morbidity and mortality in
newborns and children having or at risk for
heritable disorders.
Agenda: The meeting will be devoted to
the decision making process for candidate
conditions on the Newborn Screening Panel
as well as the continued work and reports by
the Committee’s subcommittees on laboratory
standards and procedures, follow-up
treatment, education and training.
Proposed agenda items are subject to
change.
Time will be provided each day for public
comment. Individuals who wish to provide
public comment or who plan to attend the
meeting and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should notify
the ACHDGDNC Executive Secretary,
Michele A. Lloyd-Puryear, M.D., Ph.D.
(contact information provided below).
Contact Person: Anyone interested in
obtaining a roster of members or other
relevant information should write or contact
Michele A. Lloyd-Puryear, M.D., Ph.D.,
Maternal and Child Health Bureau, Health
Resources and Services Administration,
Room 18A–19, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland 20857,
Telephone (301) 443–1080. Information on
the Advisory Committee is available at https://
mchb.hrsa.gov/programs/genetics/committee.
Dated: May 3, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–7020 Filed 5–8–06; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Tribal Management Grant Program
Announcement Type: New
Discretionary Funding Cycle for Fiscal
Year 2007.
Funding Announcement Number:
HHS–2007–IHS–TMP–0001.
Catalog of Federal Domestic
Assistance Number: 93.228.
Key Dates: Training: Application
Requirements Session: May 10–11 and
June 14–15, 2006; Grantwriting Session:
May 22–26, 2006; Application Deadline
Date: August 4, 2006; Review Date:
October 2–6, 2006; Application
Notification: November 13, 2006;
Earliest Anticipated Start Date: January
1, 2007.
I. Funding Opportunity Description
The Indian Health Service (IHS)
announces competitive grant
applications for the Tribal Management
Grant (TMG) Program. This program is
authorized under section 103(b)(2) and
section 103(e) of the Indian SelfDetermination and Education
Assistance Act, Public Law 93–638, as
amended. The TMG Program is
described at 93.228 in the Catalog of
Federal Domestic Assistance.
The TMG program is a national
competitive discretionary grant program
pursuant to 45 CFR part 75 and 45 CFR
part 92 established to assist Federallyrecognized Tribes and Triballysanctioned Tribal organizations in
assuming all or part of existing IHS
programs, services, functions, and
activities (PSFA) through a Title I
contract and to assist established Title I
contractors and Title V compactors to
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 71, Number 89 (Tuesday, May 9, 2006)]
[Notices]
[Pages 26969-26970]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-06-0469]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National Program of Cancer Registries--Cancer Surveillance System--
Extension (OMB number 0920-0469)--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The American Cancer Society estimated that about 1.37 million
Americans were newly diagnosed with cancer in 2005 and that about
570,000 died from cancer in that same year. The National Institutes of
Health estimates that in 2005, the cost of cancer was about $209
billion, including $74 billion direct costs to treat cancer, and $136
billion indirect costs in lost productivity due to illness and
premature death.
In 2002, CDC implemented the National Program of Cancer Registries
(NPCR)--Cancer Surveillance System (CSS) to collect, evaluate and
disseminate cancer incidence data collected by population-based cancer
registries. In 2002, CDC began annually publishing United States Cancer
Statistics (USCS). The latest USCS report published in 2005 provided
cancer statistics for 93% of the United States population from all
cancer registries whose data met national data standards. Prior to the
publication of USCS, at the national level, cancer incidence data were
available for only 14% of the population of the United States.
With this expanded coverage of the U.S. population, it will now be
possible
[[Page 26970]]
to better describe geographic variation in cancer incidence throughout
the country and provide incidence data on minority populations and rare
cancers to further plan and evaluate state and national cancer control
and prevention efforts.
Therefore, CDCs, NCCDPHP, Division of Cancer Prevention and Control
proposes to continue to aggregate existing cancer incidence data from
states funded by the National Program of Cancer Registries into a
national surveillance system.
These data are already collected and aggregated at the state level.
Thus the additional burden for the states is small. Funded states are
asked to continue to report cancer incidence data to CDC on an annual
basis. Each state is requested to report a cumulative file containing
incidence data from the first diagnosis year for which the cancer
registry collected data with the assistance of NPCR funds (e.g., 1995)
through to 12 months past the close of the most recent diagnosis year
(e.g., 2004).
NCCPHP is requesting a 3-year clearance for this project. There are
no costs to respondents except their time to participate in the survey.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Respondents respondents responses per response (in hours
resondent hours)
----------------------------------------------------------------------------------------------------------------
States, Territories, and the District of 63 1 2 126
Columbia (Cancer Registries)...................
---------------------------------------------------------------
Total....................................... .............. .............. .............. 126
----------------------------------------------------------------------------------------------------------------
Dated: May 3, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-7019 Filed 5-8-06; 8:45 am]
BILLING CODE 4163-18-P
